↓ Skip to main content

Update in Antifungal Therapy of Dermatophytosis

Overview of attention for article published in Mycopathologia, May 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

patent
4 patents
wikipedia
6 Wikipedia pages

Citations

dimensions_citation
243 Dimensions

Readers on

mendeley
230 Mendeley
Title
Update in Antifungal Therapy of Dermatophytosis
Published in
Mycopathologia, May 2008
DOI 10.1007/s11046-008-9109-0
Pubmed ID
Authors

Aditya K. Gupta, Elizabeth A. Cooper

Abstract

Treatment of dermatophyte infection involves primarily oral and/or topical formulations of azoles or allylamines, particularly itraconazole and terbinafine. Topical medications applied once or twice daily are the primary treatment indicated for tinea corporis/cruris, and tinea pedis/manuum. Use of oral antifungals may be practical where the tinea involvement is extensive or chronic, or where application of a topical is not feasible. For tinea unguium (onychomycosis) and tinea capitis, oral therapies are the primary treatments provided. Recently, topical amorolfine and ciclopirox formulations have been approved for use in milder onychomycosis cases, and their role in the treatment of the different clinical forms of onychomycosis is currently being defined. Relapse of infection remains a problem, particularly with tinea pedis/unguium. Appropriate follow-up duration and education of patients on proper foot hygiene are also important components in providing effective therapy.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 230 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Portugal 1 <1%
Unknown 229 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 33 14%
Student > Postgraduate 26 11%
Student > Bachelor 23 10%
Student > Ph. D. Student 22 10%
Student > Doctoral Student 16 7%
Other 40 17%
Unknown 70 30%
Readers by discipline Count As %
Medicine and Dentistry 66 29%
Pharmacology, Toxicology and Pharmaceutical Science 23 10%
Agricultural and Biological Sciences 23 10%
Immunology and Microbiology 12 5%
Biochemistry, Genetics and Molecular Biology 9 4%
Other 19 8%
Unknown 78 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 January 2023.
All research outputs
#4,897,716
of 23,549,388 outputs
Outputs from Mycopathologia
#87
of 1,077 outputs
Outputs of similar age
#15,925
of 83,163 outputs
Outputs of similar age from Mycopathologia
#3
of 12 outputs
Altmetric has tracked 23,549,388 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,077 research outputs from this source. They receive a mean Attention Score of 3.6. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 83,163 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.